Annual SG&A
$33.16 M
+$2.07 M+6.66%
31 December 2023
Summary:
Tenaya Therapeutics annual selling, general & administrative expenses is currently $33.16 million, with the most recent change of +$2.07 million (+6.66%) on 31 December 2023. During the last 3 years, it has risen by +$14.74 million (+80.06%). TNYA annual SG&A is now at all-time high.TNYA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.36 M
-$1.81 M-22.18%
30 September 2024
Summary:
Tenaya Therapeutics quarterly selling, general & administrative expenses is currently $6.36 million, with the most recent change of -$1.81 million (-22.18%) on 30 September 2024. Over the past year, it has dropped by -$2.22 million (-25.87%). TNYA quarterly SG&A is now -27.73% below its all-time high of $8.80 million, reached on 31 December 2022.TNYA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.79 B
-$117.23 M-6.99%
30 September 2024
Summary:
Tenaya Therapeutics TTM selling, general & administrative expenses is currently -$1.79 billion, with the most recent change of -$117.23 million (-6.99%) on 30 September 2024. Over the past year, it has dropped by -$1.83 billion (-5511.88%). TNYA TTM SG&A is now -2066.72% below its all-time high of $33.74 million, reached on 31 March 2024.TNYA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNYA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -25.9% | -5511.9% |
| 3 y3 years | +80.1% | +22.1% | -9844.8% |
| 5 y5 years | +626.5% | - | - |
TNYA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +80.1% | -27.7% | +22.1% | -264.7% | at low |
| 5 y | 5 years | at high | +626.5% | -27.7% | +232.3% | -2066.7% | at low |
| alltime | all time | at high | +626.5% | -27.7% | +232.3% | -2066.7% | at low |
Tenaya Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.36 M(-22.2%) | $31.82 M(-4.4%) |
| June 2024 | - | $8.17 M(-6.1%) | $33.29 M(-1.3%) |
| Mar 2024 | - | $8.71 M(+1.5%) | $33.74 M(+1.8%) |
| Dec 2023 | $33.16 M(+6.7%) | $8.58 M(+9.6%) | $33.16 M(-0.7%) |
| Sept 2023 | - | $7.83 M(-9.3%) | $33.38 M(+0.9%) |
| June 2023 | - | $8.63 M(+6.3%) | $33.09 M(+2.7%) |
| Mar 2023 | - | $8.12 M(-7.8%) | $32.20 M(+3.6%) |
| Dec 2022 | $31.08 M | $8.80 M(+16.7%) | $31.08 M(+13.1%) |
| Sept 2022 | - | $7.54 M(-2.6%) | $27.49 M(+8.6%) |
| June 2022 | - | $7.74 M(+10.6%) | $25.31 M(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $7.00 M(+34.3%) | $21.90 M(+18.9%) |
| Dec 2021 | $18.41 M(+135.7%) | $5.21 M(-2.7%) | $18.41 M(+21.5%) |
| Sept 2021 | - | $5.36 M(+23.7%) | $15.16 M(+28.7%) |
| June 2021 | - | $4.33 M(+23.2%) | $11.78 M(+25.8%) |
| Mar 2021 | - | $3.52 M(+79.5%) | $9.36 M(+19.8%) |
| Dec 2020 | $7.81 M(+71.2%) | - | - |
| Dec 2020 | - | $1.96 M(-0.7%) | $7.81 M(+33.4%) |
| Sept 2020 | - | $1.97 M(+3.0%) | $5.86 M(+50.8%) |
| June 2020 | - | $1.91 M(-2.8%) | $3.88 M(+97.2%) |
| Mar 2020 | - | $1.97 M | $1.97 M |
| Dec 2019 | $4.56 M | - | - |
FAQ
- What is Tenaya Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly SG&A year-on-year change?
- What is Tenaya Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Tenaya Therapeutics?
- What is Tenaya Therapeutics TTM SG&A year-on-year change?
What is Tenaya Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of TNYA is $33.16 M
What is the all time high annual SG&A for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual selling, general & administrative expenses is $33.16 M
What is Tenaya Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of TNYA is $6.36 M
What is the all time high quarterly SG&A for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly selling, general & administrative expenses is $8.80 M
What is Tenaya Therapeutics quarterly SG&A year-on-year change?
Over the past year, TNYA quarterly selling, general & administrative expenses has changed by -$2.22 M (-25.87%)
What is Tenaya Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of TNYA is -$1.79 B
What is the all time high TTM SG&A for Tenaya Therapeutics?
Tenaya Therapeutics all-time high TTM selling, general & administrative expenses is $33.74 M
What is Tenaya Therapeutics TTM SG&A year-on-year change?
Over the past year, TNYA TTM selling, general & administrative expenses has changed by -$1.83 B (-5511.88%)